Cargando…
ANGPTL8 is a negative regulator in pathological cardiac hypertrophy
Pathological cardiac hypertrophy is an independent risk factor for heart failure and is considered a target for the treatment of heart failure. However, the mechanisms underlying pathological cardiac hypertrophy remain largely unknown. We aimed to investigate the role of angiopoietin-like protein 8...
Autores principales: | Hu, Lin, Wei, Jiarui, Zhang, Yue, Wang, Ziyuan, Tang, Junming, Tang, Jian, Gao, Yujiu, Zhang, Xiaoqiao, Li, Yifan, Liu, Yantong, Ma, Shinan, Guo, Xingrong, Zhang, Qiufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293964/ https://www.ncbi.nlm.nih.gov/pubmed/35851270 http://dx.doi.org/10.1038/s41419-022-05029-8 |
Ejemplares similares
-
ANGPTL8 promotes adipogenic differentiation of mesenchymal stem cells: potential role in ectopic lipid deposition
por: Tang, Jian, et al.
Publicado: (2022) -
ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways
por: Zhang, Zongli, et al.
Publicado: (2022) -
Dual role of ANGPTL8 in promoting tumor cell proliferation and immune escape during hepatocarcinogenesis
por: Gao, Yujiu, et al.
Publicado: (2023) -
Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism
por: Yang, Longyan, et al.
Publicado: (2019) -
The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2018)